CA2358356A1 - Pharmaceutical composition containing citalopram - Google Patents

Pharmaceutical composition containing citalopram Download PDF

Info

Publication number
CA2358356A1
CA2358356A1 CA002358356A CA2358356A CA2358356A1 CA 2358356 A1 CA2358356 A1 CA 2358356A1 CA 002358356 A CA002358356 A CA 002358356A CA 2358356 A CA2358356 A CA 2358356A CA 2358356 A1 CA2358356 A1 CA 2358356A1
Authority
CA
Canada
Prior art keywords
active ingredient
dosage form
unit dosage
citalopram
solid unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002358356A
Other languages
English (en)
French (fr)
Inventor
Per Holm
Ken Liljegren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of CA2358356A1 publication Critical patent/CA2358356A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002358356A 2001-01-05 2001-10-04 Pharmaceutical composition containing citalopram Abandoned CA2358356A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100016 2001-01-05
DKPA200100016 2001-01-05

Publications (1)

Publication Number Publication Date
CA2358356A1 true CA2358356A1 (en) 2002-01-20

Family

ID=8159961

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002358356A Abandoned CA2358356A1 (en) 2001-01-05 2001-10-04 Pharmaceutical composition containing citalopram

Country Status (22)

Country Link
US (1) US20040058989A1 (sh)
EP (1) EP1351667A1 (sh)
JP (1) JP2004517111A (sh)
KR (1) KR20030070088A (sh)
CN (1) CN1484523A (sh)
AU (1) AU2001100195B4 (sh)
BG (1) BG108034A (sh)
BR (1) BR0206272A (sh)
CA (1) CA2358356A1 (sh)
CZ (1) CZ20032119A3 (sh)
EA (1) EA005596B1 (sh)
HR (1) HRP20030546A2 (sh)
HU (1) HUP0302531A3 (sh)
IL (1) IL156547A0 (sh)
IS (1) IS6857A (sh)
MX (1) MXPA03005965A (sh)
NO (1) NO20033073D0 (sh)
PL (1) PL362358A1 (sh)
SK (1) SK9912003A3 (sh)
WO (1) WO2002053133A1 (sh)
YU (1) YU54503A (sh)
ZA (1) ZA200304860B (sh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406592C (en) * 2002-10-04 2003-09-30 Duchesnay Inc. Method of preparing pharmaceutical dosage forms containing multiple active ingredients
AU2004222339A1 (en) * 2003-03-14 2004-09-30 Nirmal Mulye A process for preparing sustained release tablets
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006123243A2 (en) * 2005-05-20 2006-11-23 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram

Also Published As

Publication number Publication date
NO20033073L (no) 2003-07-04
EA200300768A1 (ru) 2003-10-30
HUP0302531A3 (en) 2007-06-28
PL362358A1 (en) 2004-10-18
IL156547A0 (en) 2004-01-04
BR0206272A (pt) 2003-12-30
AU2001100195A4 (en) 2001-08-16
WO2002053133A1 (en) 2002-07-11
AU2001100195B4 (en) 2001-12-20
HRP20030546A2 (en) 2005-06-30
EP1351667A1 (en) 2003-10-15
US20040058989A1 (en) 2004-03-25
CN1484523A (zh) 2004-03-24
HUP0302531A2 (hu) 2003-11-28
ZA200304860B (en) 2004-06-30
BG108034A (bg) 2005-02-28
KR20030070088A (ko) 2003-08-27
SK9912003A3 (en) 2003-12-02
CZ20032119A3 (en) 2004-03-17
EA005596B1 (ru) 2005-04-28
IS6857A (is) 2003-06-23
YU54503A (sh) 2006-05-25
NO20033073D0 (no) 2003-07-04
JP2004517111A (ja) 2004-06-10
MXPA03005965A (es) 2003-09-05

Similar Documents

Publication Publication Date Title
EP1414435B1 (en) Crystalline composition containing escitalopram
AU2002355624A1 (en) Crystalline composition containing escitalopram
AU2001100198B4 (en) Pharmaceutical composition containing citalopram
CA2358356A1 (en) Pharmaceutical composition containing citalopram
EP2086509A1 (en) Escitalopram and solid pharmaceutical composition comprising the same
AU2002216944A1 (en) Pharmaceutical composition containing citalopram
US20030109577A1 (en) Pharmaceutical composition containing citalopram
CN100500157C (zh) 一种含水溶性药物缓释片及制备方法
GB2376233A (en) Crystals of a pharmaceutically acceptable salt of citalopram wherein the median particle size of the crystals is at least 40 microns
ZA200300561B (en) Pharmaceutical composition containing citalopram.
WO2005051374A1 (en) Tablets of citalopram hydrobromide

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued